A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
|Articles|July 12, 2011
Poll: Will the Swedish Two-County Trial Change How You Recommend Mammograms?
Author(s)OBGYN.net Staff
A prospective case-control study from Sweden has found long-term benefits of regular mammography screening, including a positive impact on reducing mortality.
Advertisement
A prospective case-control
Vote in the poll and share your comments below.
Advertisement
Related to this article
The FDA accepted an sNDA and granted priority review for elinzanetant to treat VMS in women receiving endocrine therapy to treat or prevent HR+ breast cancer.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Maternal high egg and peanut intake in pregnancy and lactation did not lower infant IgE-mediated egg or peanut allergy at 1 year in PrEggNut.
Missed the rollout of ACOG's 2026 Maternal Immunization Schedule? This FAQ breaks down everything clinicians need to know about the new guidance.
Jean Cunningham, PharmD, BCPS, explains how ob-gyns can link anxiety, sleep disruption, and cognitive changes to perimenopause—and catch it earlier.
The well-woman visit drives preventive care, but its structure leaves little room for the complexity of women's lives, according to Barbara Levy, MD.
A review finds post-miscarriage ultrasound heterogeneity is common and that symptoms, not endometrial thickness, should guide management after EPL.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Maternal egg, peanut diet in pregnancy, and associated infant allergy
2
The annual well-woman visit needs an upgrade
3
Perimenopause and mental health: Beyond hormonal vs psychological
4
Wen Shen, MD, on screening red flags during perimenopause care
5